Relation of BMI and Postmenopausal Duration With Antioxidant and Anti-Inflammatory Effects of Raloxifene Treatment in Women With Osteoporosis: A Preliminary Report
Articles > Article · 2012
Authors: Yasemin AKÇAY, Sibel EYİGÖR, Bilal İLANBEY, Muammer KARADENIZ, Yeşim KİRAZLI, Eser YILDIRIM SÖZMEN
TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, Journal Indexed in SCI Expanded, International, 2012, vol 58, pp 29-35
DOI: 10.4274/tftr.61687
Summary
Objective: We have not identified any objective evidence in the literature about the effects of raloxifene treatment on the antioxidant and anti-inflammatory markers. We investigated the antioxidant/anti-inflammatory effects of raloxifene and the association of its antioxidant/anti-inflammatory effects with body mass index (BMI) and postmenopausal period in women with osteoporosis (OP).